HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hua Yan Selected Research

Wounds and Injuries (Trauma)

1/2024Vitreous Olink proteomics reveals inflammatory biomarkers for diagnosis and prognosis of traumatic proliferative vitreoretinopathy.
1/2023An interpretable model predicts visual outcomes of no light perception eyes after open globe injury.
9/2022Guideline for the treatment of no light perception eyes induced by mechanical ocular trauma.
4/2022The application of clinical registries in ophthalmic trauma-the International Globe and Adnexal Trauma Epidemiology Study (IGATES).
3/2022Case series: Two cases of severe retinal cicatricial contraction after vitrectomy for open-globe injury in patients with skin keloid.
1/2021Risk Factors for Band Keratopathy in Aphakic Eyes With Silicone Oil Tamponade for Open-Globe Injuries: A Multicenter Case-Control Study.
1/2021mmu-miR-145a-5p Accelerates Diabetic Wound Healing by Promoting Macrophage Polarization Toward the M2 Phenotype.
1/2021The Role of Intravitreal Anti-VEGF Agents in Rabbit Eye Model of Open-Globe Injury.
5/2020Characteristics and treatments of ocular blast injury in Tianjin explosion in China.
1/2019Effect of etanercept on post-traumatic proliferative vitreoretinopathy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hua Yan Research Topics

Disease

51Neoplasms (Cancer)
02/2024 - 04/2004
19Diabetic Retinopathy (Retinopathy, Diabetic)
01/2024 - 01/2007
18Inflammation (Inflammations)
01/2024 - 05/2012
17Glioma (Gliomas)
02/2024 - 09/2012
16Wounds and Injuries (Trauma)
01/2024 - 01/2006
13Multiple Myeloma
01/2024 - 10/2012
10Infections
03/2022 - 06/2006
7Brain Injuries (Brain Injury)
04/2024 - 01/2014
7Cataract (Cataracts)
03/2023 - 05/2008
7Carcinogenesis
01/2022 - 01/2017
6Proliferative Vitreoretinopathy
01/2024 - 11/2014
6Endophthalmitis (Ophthalmia)
12/2023 - 08/2009
6Optic Nerve Injuries
03/2023 - 12/2010
6Hypoxia (Hypoxemia)
12/2022 - 12/2005
6Insulin Resistance
05/2022 - 01/2017
6Neoplasm Metastasis (Metastasis)
05/2022 - 06/2011
6Acute Promyelocytic Leukemia
04/2015 - 04/2004
5Asthma (Bronchial Asthma)
11/2023 - 01/2020
5Fibrosis (Cirrhosis)
01/2022 - 04/2011
5Traumatic Brain Injuries (Traumatic Brain Injury)
01/2020 - 05/2012
5Necrosis
01/2020 - 03/2007
4Retinal Detachment (Retinal Detachments)
12/2023 - 01/2017
4Glioblastoma (Glioblastoma Multiforme)
11/2023 - 01/2020
4Glaucoma
10/2023 - 01/2021
4Macular Degeneration (Age-Related Maculopathy)
03/2023 - 01/2021
4Myocardial Infarction
01/2023 - 06/2011
4Choroidal Neovascularization
01/2023 - 05/2008
4Non-alcoholic Fatty Liver Disease
12/2019 - 01/2017
4Ischemia
08/2015 - 10/2005
4Sarcoma (Soft Tissue Sarcoma)
06/2011 - 03/2005
3Retinal Perforations
01/2024 - 01/2007
3Brain Edema (Cerebral Edema)
01/2023 - 11/2019
3Thrombosis (Thrombus)
01/2023 - 06/2011
3Obesity
10/2021 - 08/2015
3Cicatrix (Scar)
09/2021 - 02/2007
3Coronary Artery Disease (Coronary Atherosclerosis)
04/2021 - 12/2015
3Diabetes Mellitus
01/2021 - 05/2012
3Vitreous Hemorrhage
01/2021 - 04/2010
3Foreign Bodies (Foreign Body)
05/2020 - 01/2017
3Uveitis
08/2017 - 11/2013
3Leukemia
04/2015 - 04/2004
2Endometrial Neoplasms (Endometrial Cancer)
03/2024 - 11/2018
2Blindness (Hysterical Blindness)
11/2023 - 03/2023
2Eye Diseases (Eye Disease)
03/2023 - 01/2022
2Seizures (Absence Seizure)
01/2023 - 11/2016

Drug/Important Bio-Agent (IBA)

23Proteins (Proteins, Gene)FDA Link
01/2024 - 12/2005
17Retinaldehyde (Retinal)IBA
12/2023 - 01/2007
14Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 - 08/2005
13Biomarkers (Surrogate Marker)IBA
01/2024 - 01/2005
9AntigensIBA
01/2023 - 06/2006
8MicroRNAs (MicroRNA)IBA
05/2022 - 08/2013
7Long Noncoding RNAIBA
02/2024 - 01/2019
6Doxorubicin (Adriamycin)FDA LinkGeneric
04/2024 - 12/2006
6LipidsIBA
06/2021 - 12/2015
52-toluenesulfonamide (OTS)IBA
01/2023 - 05/2012
4Therapeutic UsesIBA
04/2024 - 11/2013
4Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
11/2023 - 06/2021
4EnzymesIBA
11/2022 - 03/2009
4Silicone OilsIBA
01/2022 - 09/2008
4LigandsIBA
11/2021 - 12/2010
4CytokinesIBA
01/2021 - 02/2015
4Glucose (Dextrose)FDA LinkGeneric
01/2020 - 01/2017
4Caspase 3 (Caspase-3)IBA
01/2019 - 12/2010
4Simvastatin (Zocor)FDA LinkGeneric
08/2015 - 05/2012
4Arsenic Trioxide (Trisenox)FDA Link
09/2014 - 04/2004
3Reactive Oxygen Species (Oxygen Radicals)IBA
11/2023 - 03/2022
3Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2023 - 04/2004
3Peptides (Polypeptides)IBA
01/2023 - 08/2017
3Circular RNAIBA
05/2022 - 01/2020
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2021 - 05/2012
3Bortezomib (Velcade)FDA Link
09/2021 - 09/2014
3KH902 fusion proteinIBA
09/2021 - 01/2021
3Gu-Ben-Fang-Xiao decoctionIBA
06/2021 - 01/2020
3Small Interfering RNA (siRNA)IBA
07/2019 - 10/2014
3Phosphoglycerate Kinase (Kinase, Phosphoglycerate)IBA
08/2017 - 09/2012
3erucylphosphocholineIBA
10/2016 - 12/2012
3VaccinesIBA
01/2014 - 11/2010
2ezrinIBA
03/2024 - 11/2018
2Fatty Acids (Saturated Fatty Acids)IBA
02/2024 - 06/2021
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
02/2024 - 01/2020
2Oleic Acid (Oleate)IBA
02/2024 - 06/2015
2IronIBA
02/2024 - 12/2022
2OvalbuminIBA
11/2023 - 01/2021
2Temozolomide (Temodar)FDA LinkGeneric
11/2023 - 01/2023
26-methyladenineIBA
03/2023 - 01/2022
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2023 - 01/2021

Therapy/Procedure

28Therapeutics
11/2023 - 01/2014
16Vitrectomy
12/2023 - 01/2006
6Intravitreal Injections
02/2023 - 05/2008
6Drug Therapy (Chemotherapy)
12/2022 - 09/2016
5Radiotherapy
12/2023 - 09/2012
4Chinese Traditional Medicine (Traditional Chinese Medicine)
04/2024 - 01/2019
3Stents
01/2023 - 06/2011
3Percutaneous Coronary Intervention
01/2023 - 03/2015
3Phacoemulsification
06/2021 - 01/2016
3Lasers (Laser)
07/2018 - 01/2005
3Light Coagulation
01/2016 - 04/2010
2Aftercare (After-Treatment)
01/2024 - 06/2006
2Immunomodulation
12/2023 - 01/2021
2Intravenous Injections
01/2023 - 01/2019